FDA Warning Letter to Diamond Distributions LLC (2026-06-16) — Foreign Supplier Verification Program (FSVP)
Letter issued · posted to fda.gov .
Subject as published: Foreign Supplier Verification Program (FSVP)
TL;DR
In short: The FDA issued a warning letter to Diamond Distributions LLC (CEO Aleksandr Oganezov, Irwindale, CA) on June 16, 2026, following a May 18, 2026 Foreign Supplier Verification Program (FSVP) inspection finding the company failed to develop, maintain, and follow required FSVP documentation for imported foods including dessert au chocolate, chocolate bars, and chocolate products. The FDA stated Diamond Distributions did not respond to a Form FDA 483a issued at inspection conclusion and required a written response within 15 working days addressing corrective actions, with warning that failure to comply could result in detention without physical examination of imported foods or refusal of admission under section 801(a)(3) of the FD&C Act.
Argus analysis
# FDA Warning Letter Analysis: Diamond Distributions LLC
**Company and Findings**
Diamond Distributions LLC, a food importer based in Irwindale, California, received a warning letter from the FDA's Office of Inspections and Investigations on June 16, 2026, following a Foreign Supplier Verification Program (FSVP) inspection conducted May 18, 2026. The FDA determined that the company failed to develop, maintain, and follow an FSVP for multiple imported food products, including dessert items and chocolate bars sourced from foreign suppliers. The inspection revealed a systemic compliance gap: no FSVP documentation existed for any foods the company imports.
**Regulatory Citations and Their Meaning**
The violations center on 21 CFR Part 1, Subpart L and Section 805 of the Federal Food, Drug, and Cosmetic Act. These regulations require importers to establish risk-based verification programs ensuring that foreign-supplied foods meet U.S. safety standards before entry. In practice, this means importers must document supplier audits, hazard analyses, corrective actions, and record-keeping procedures. The absence of any FSVP—not merely deficient documentation—represents a foundational compliance failure rather than a procedural shortfall.
**Response Timeline and Industry Monitoring Points**
Diamond Distributions must respond within 15 working days, addressing specific corrective actions with supporting documentation. The company faces escalating enforcement: the FDA signaled potential detention without physical examination (DWPE) of imported products and possible refusal of admission under Import Alert #99-41. Peer compliance officers should monitor whether the company submits substantive FSVP documentation or requests extension. A weak or delayed response typically precedes import holds or administrative detention, making this a critical juncture for the importer's operational continuity.
Severity context
Low severity. Procedural or narrow scope; most peer companies resolve in the 15-business-day response window without structural change.
Regulatory background
FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER Diamond Distributions LLC MARCS-CMS 731966 — June 16, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Express Delivery Product: Food & Beverages Recipient: Recipient Name Aleksandr Oganezov Recipient Title Chief Executive Officer Diamond Distributions LLC 5462 Diaz St Irwindale , CA 91706 United States (b)(6), (b)(7)(C) Issuing Office: Office of Inspections and Investigations United States June 16, 2026 WARNING LETTER Re: CMS #731966 Dear Mr. Oganezov: On May 18, 2026, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of Diamond Distributions LLC located at 5462 Diaz St, Irwindale, CA 91706. This inspection was conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L. The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable U.S. food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplier-verification-programs-fsvp-importers-food-humans-and-animals. During the inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods you import. Because of these significant violations, you are not in compliance with section 805 of the FD&C Act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations. We have not received your response to the Form FDA 483a issued on May 18, 2006. Your significant violations of the FSVP regulation are as follows: You did not develop, maintain, and follow an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for any of the foods you import, including each of the following foods: (b)(4) Dessert Au Chocolate imported from (b)(4) Chocolate Bar (b)(4) imported from (b)(4) Chocolate (b)(4) imported from (b)(4) The above violations are not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&C Act and the implementing regulation in 21 CFR part 1, subpart L. This letter notifies you of our concerns and provides you an opportunity to address them. If you do not adequately address this matter, we may take further action. For instance, we may take action under section 801(a)(3) of the FD&C Act (21 U.S.C. 381(a)(3)) to refuse admission of the food you import for which you appear to be in violation of section 805. We may place the food from the i…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What is the regulatory background for a Warning Letter warning letter?
- FDA Warning Letters are administratively non-binding but signal that recurring non-compliance may escalate to injunction, seizure, import alert, or Application Integrity Policy invocation.
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- Has Diamond Distributions LLC had FDA enforcement actions before?
- This is the only FDA Warning Letter Argus HQ has on file for Diamond Distributions LLC as of 2026-07-14. Argus ingests new FDA enforcement records daily.
- What FDA violations was Diamond Distributions LLC cited for?
- The FDA Warning Letter to Diamond Distributions LLC (issuing office: Office of Inspections and Investigations) cites: Foreign Supplier Verification Program (FSVP). Classification: Warning Letter.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Warning Letter to Diamond Distributions LLC (2026-06-16) — Foreign Supplier Verification Program (FSVP). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-diamond-distributions-llc-2026-06-16-warning-letter
"FDA Warning Letter to Diamond Distributions LLC (2026-06-16) — Foreign Supplier Verification Program (FSVP)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-diamond-distributions-llc-2026-06-16-warning-letter.
Argus HQ Research. "FDA Warning Letter to Diamond Distributions LLC (2026-06-16) — Foreign Supplier Verification Program (FSVP)." Digital Empire Holdings LLC. Accessed July 18, 2026. https://argushq.ai/fda/warning-letter/fda-wl-diamond-distributions-llc-2026-06-16-warning-letter.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_diamond_distributions_llc_2026_06_16_warning_letter_2026,
title = {FDA Warning Letter to Diamond Distributions LLC (2026-06-16) — Foreign Supplier Verification Program (FSVP)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-diamond-distributions-llc-2026-06-16-warning-letter},
note = {Accessed: July 18, 2026}
}